Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Salsabil, Labiba
Autres auteurs:	Chowdhury, Namara Mariam
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Accès en ligne:	http://hdl.handle.net/10361/23932

Documents similaires

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
par: Dey, Manashi
Publié: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
par: Halim, Rabea
Publié: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
par: Zaman, Rubaiyat
Publié: (2024)

Targeting circular RNA for cardiovascular diseases
par: Sarkar, Deepannita
Publié: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
par: Islam, Md. Raihanul
Publié: (2024)

Implications of unusual non-coding RNAs in human diseases
par: Ahmed, Tazkia
Publié: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
par: Mostofa, Golam
Publié: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

A review on optogenetics and its potential in neurological disorder management
par: Armin, Fariza
Publié: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
par: Suraiya, Tasnia Iffat
Publié: (2023)

Gene editing for neurodegenerative diseases-A review
par: Sharna, Anika Islam
Publié: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
par: Ferdous, Labiba
Publié: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
par: Annee, Israt Jahan
Publié: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
par: Tasneem, Sadia
Publié: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
par: Nawar, Numia
Publié: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
par: Afsana, Nourin
Publié: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
par: Ahmad, Rafid Uddin, et autres
Publié: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
par: Mithila, Sabekun Nahar
Publié: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
par: Mahaleka, Aarshi
Publié: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
par: Islam, Md. Rakibul
Publié: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
par: Karmaker, Swastika
Publié: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
par: Key, Nasrin Sultana
Publié: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
par: Rawshan, A. E. Maisha
Publié: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
par: Chowdhury, Amal
Publié: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
par: Afreen, Nuraia
Publié: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
par: Naureen, Ishrat
Publié: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
par: Abedin, Khondokar Mezbahul
Publié: (2023)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
par: Tamanna, Mst. Taskia
Publié: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
par: Nuha, Nabiha Tahsin
Publié: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
par: Asaduzzaman, et autres
Publié: (2021)